392 related articles for article (PubMed ID: 25633718)
1. A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma.
Ge YZ; Wu R; Xin H; Zhu M; Lu TZ; Liu H; Xu Z; Yu P; Zhao YC; Li MH; Hu ZK; Zhao Y; Zhong B; Xu X; Zhou LH; Xu LW; Wu JP; Li WC; Zhu JG; Jia RP
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1291-9. PubMed ID: 25633718
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma.
Ge YZ; Xin H; Lu TZ; Xu Z; Yu P; Zhao YC; Li MH; Zhao Y; Zhong B; Xu X; Zhou LH; Wu R; Xu LW; Wu JP; Li WC; Zhu JG; Jia RP
Sci Rep; 2015 May; 5():10328. PubMed ID: 25981392
[TBL] [Abstract][Full Text] [Related]
4. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
[TBL] [Abstract][Full Text] [Related]
5. A
Ge YZ; Xu LW; Zhou CC; Lu TZ; Yao WT; Wu R; Zhao YC; Xu X; Hu ZK; Wang M; Yang XB; Zhou LH; Zhong B; Xu Z; Li WC; Zhu JG; Jia RP
J Cancer; 2017; 8(13):2643-2652. PubMed ID: 28900502
[No Abstract] [Full Text] [Related]
6. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
[TBL] [Abstract][Full Text] [Related]
7. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
[TBL] [Abstract][Full Text] [Related]
8. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A
PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447
[TBL] [Abstract][Full Text] [Related]
9. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Zhang J; Chong CC; Chen GG; Lai PB
PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
[TBL] [Abstract][Full Text] [Related]
10. A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis.
Liang B; Zhao J; Wang X
PLoS One; 2017; 12(6):e0180660. PubMed ID: 28662155
[TBL] [Abstract][Full Text] [Related]
11. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
[No Abstract] [Full Text] [Related]
12. Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma.
Kowalik CG; Palmer DA; Sullivan TB; Teebagy PA; Dugan JM; Libertino JA; Burks EJ; Canes D; Rieger-Christ KM
BJU Int; 2017 Sep; 120(3):428-440. PubMed ID: 28432832
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
[TBL] [Abstract][Full Text] [Related]
15. New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.
Qi Y; Wang L; Wang K; Peng Z; Ma Y; Zheng Z; Shang D; Xu W; Zheng J
Biomed Pharmacother; 2019 Mar; 111():821-834. PubMed ID: 30616081
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma.
Yin H; Wang X; Zhang X; Wang Y; Zeng Y; Xiong Y; Li T; Lin R; Zhou Q; Ling H; Zhou F; Zhou Y
Cancer Sci; 2018 Oct; 109(10):3336-3349. PubMed ID: 30152187
[TBL] [Abstract][Full Text] [Related]
17. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
[TBL] [Abstract][Full Text] [Related]
18. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.
Guan L; Tan J; Li H; Jin X
Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611
[TBL] [Abstract][Full Text] [Related]
19. A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs.
Yu Z; Lu C; Lu B; Gao H; Liang R; Xiang W
BMC Genomics; 2023 Mar; 24(1):162. PubMed ID: 36991314
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
Zhou L; Liu S; Li X; Yin M; Li S; Long H
Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
